Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.

The medical and pharmaceutical distributor also has global operations, with business in more than 35 countries and more than 10,000 specialty physician offices and clinics. Cardinal Health serves in total around 27 million patients through its different business segments.

Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!

*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.

Fridge van conversionkit

CAH shares gained 1.9% to 102.58 on Tuesday. Cardinal Health is in a long consolidation, with an official buy point of 116.04, from a March 13 high, according to MarketSurge analysis.

Cardinal offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

Analysts expect fiscal 2025 EPS to remain flat with 2024, coming in at $7.53, while Cardinal Health's forecast represents a 2% increase at the top end of its guidance.

Cardinal Health (CAH) stock advanced Wednesday after the multinational medical products and pharmaceuticals distributor reported better-than-expected fiscal fourth-quarter results while also hiking its fiscal 2025 profit expectations.

IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.

KoolKiy

Cardinal Health is one of three players that dominate the U.S. drug distribution picture, along with McKesson (MCK) and Cencora (COR), formerly AmerisourceBergen. All three were seen as playing an aiding role in the U.S. opioid crisis, and agreed to a $19.5 billion settlement in cases related to opioid distribution in February, 2022.

The Dublin, Ohio-based operation announced early Wednesday that fiscal Q4 earnings grew 19% to $1.84 per share while sales increased 12% to $59.87 billion. Prior to the report, analyst consensus had Cardinal Health Q4 EPS coming in at $1.73 on revenue totaling $58.64 billion, according to FactSet.

Refrigerated vankit

Cardinal Health also raised its profit guidance for fiscal 2025, expecting adjusted earnings of $7.55-$7.70 per share. The company's previous view had been around $7.50 per share.

Cardinal Health stock has a 78 Composite Rating out of a best-possible 99. Shares also have a 55 Relative Strength Rating and n 88 EPS Rating.

Cardinal Health stock ranks third in the Medical-Wholesale Drug/Supplies group. Industry peer McKesson recently missed sales estimates for the June fiscal first quarter while earnings topped views, with the help of stock buybacks.

Cardinal Health stock jumped 3,5% to 106.19 during market action on Wednesday, retesting resistance at its 200-day moving average and advancing to its highest level since April. The move back above 200-day support also broke a down sloping trendline, signaling a possible early entry for aggressive investors.